• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

伴有难治性心力衰竭的心脏结节病的临床特征与组织病理学：一例尸检病例

Clinical Features and Histopathology of Cardiac Sarcoidosis with Refractory Heart Failure: An Autopsy Case.

作者信息

Terasaki Fumio, Kuwabara Hiroko, Takeda Yoshihiro, Yamauchi Yohei, Fujita Shuichi, Nakamura Takahiro, Torii Ikuko, Hirose Yoshinobu, Hoshiga Masaaki

机构信息

Medical Education Center, Osaka Medical College, Japan.

Department of Cardiology, Osaka Medical College, Japan.

出版信息

Intern Med. 2019 Dec 15;58(24):3551-3555. doi: 10.2169/internalmedicine.3147-19. Epub 2019 Aug 21.

DOI:10.2169/internalmedicine.3147-19
PMID:31434823
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6949437/
Abstract

Treatment involving the insertion of an implantable cardioverter defibrillator and cardiac resynchronization therapy devices has markedly improved the prognosis of cardiac sarcoidosis. However, the prognosis remains poor in patients with advanced cardiac dysfunction or heart failure. We herein report the clinical course and histopathological findings of the autopsied heart of a patient with cardiac sarcoidosis with long-term refractory heart failure.

摘要

涉及植入式心脏复律除颤器和心脏再同步治疗设备的治疗方法显著改善了心脏结节病的预后。然而，对于晚期心脏功能障碍或心力衰竭患者，预后仍然较差。我们在此报告一名患有长期难治性心力衰竭的心脏结节病患者经尸检的心脏的临床病程和组织病理学发现。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c63/6949437/a976830af090/1349-7235-58-3551-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c63/6949437/19a03259aa97/1349-7235-58-3551-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c63/6949437/f9e803e2b190/1349-7235-58-3551-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c63/6949437/7ee0fdb3d8c1/1349-7235-58-3551-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c63/6949437/87fbfcb553c2/1349-7235-58-3551-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c63/6949437/25cb3e9bdfe4/1349-7235-58-3551-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c63/6949437/1995982afa69/1349-7235-58-3551-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c63/6949437/a976830af090/1349-7235-58-3551-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c63/6949437/19a03259aa97/1349-7235-58-3551-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c63/6949437/f9e803e2b190/1349-7235-58-3551-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c63/6949437/7ee0fdb3d8c1/1349-7235-58-3551-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c63/6949437/87fbfcb553c2/1349-7235-58-3551-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c63/6949437/25cb3e9bdfe4/1349-7235-58-3551-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c63/6949437/1995982afa69/1349-7235-58-3551-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c63/6949437/a976830af090/1349-7235-58-3551-g007.jpg

相似文献

1
Clinical Features and Histopathology of Cardiac Sarcoidosis with Refractory Heart Failure: An Autopsy Case.伴有难治性心力衰竭的心脏结节病的临床特征与组织病理学：一例尸检病例
Intern Med. 2019 Dec 15;58(24):3551-3555. doi: 10.2169/internalmedicine.3147-19. Epub 2019 Aug 21.
2
Outcomes in patients with high-degree atrioventricular block as the initial manifestation of cardiac sarcoidosis.以高度房室传导阻滞为心脏结节病初始表现的患者的预后。
Am J Cardiol. 2015 Feb 15;115(4):505-9. doi: 10.1016/j.amjcard.2014.11.028. Epub 2014 Nov 29.
3
[A heart insufficiency treated by glucocorticoids].
Praxis (Bern 1994). 2007 Oct 17;96(42):1643-7. doi: 10.1024/1661-8157.96.42.1643.
4
Diagnosed late cardiac sarcoidosis in a patient with atrioventricular block.一名患有房室传导阻滞的患者被诊断为晚期心脏结节病。
Br J Hosp Med (Lond). 2016 Nov 2;77(11):658-659. doi: 10.12968/hmed.2016.77.11.658.
5
Usefulness of cardiac magnetic resonance imaging in the diagnosis of cardiac myocarditis revealed by complete atrioventricular block.心脏磁共振成像在诊断完全性房室传导阻滞所致心肌心肌炎中的应用价值
Arch Cardiovasc Dis. 2014 Apr;107(4):274-5. doi: 10.1016/j.acvd.2012.05.014. Epub 2013 Jan 30.
6
Resynchronization Therapy in Cardiac Sarcoidosis and Severe Heart Failure: When Good May Not Be Good Enough.心脏结节病和严重心力衰竭中的再同步治疗：当良好可能还不够好时。
J Cardiovasc Electrophysiol. 2017 Feb;28(2):182-184. doi: 10.1111/jce.13144. Epub 2017 Jan 13.
7
Diagnosis and treatment of cardiac sarcoidosis.心脏结节病的诊断与治疗。
Heart. 2016 Feb;102(3):184-90. doi: 10.1136/heartjnl-2015-307877. Epub 2015 Dec 7.
8
Cardiac sarcoidosis.
Jpn Heart J. 1990 Mar;31(2):251-8. doi: 10.1536/ihj.31.251.
9
Risk factors and the effect of cardiac resynchronization therapy on cardiac and non-cardiac mortality in MADIT-CRT.MADIT-CRT 中的心脏再同步治疗的心脏和非心脏死亡率的风险因素及影响。
Europace. 2015 Dec;17(12):1816-22. doi: 10.1093/europace/euv201. Epub 2015 Jun 11.
10
Sustained clinical benefit of cardiac resynchronization therapy in non-LBBB patients with prolonged PR-interval: MADIT-CRT long-term follow-up.心脏再同步治疗对PR间期延长的非左束支传导阻滞患者的持续临床获益：MADIT-CRT长期随访
Clin Res Cardiol. 2016 Nov;105(11):944-952. doi: 10.1007/s00392-016-1003-z. Epub 2016 Jun 18.

引用本文的文献

1
Morphological Re-Evaluation of Cardiac Sarcoidosis　- A Case-Based Analysis of 14 Post-Mortem Japanese Hearts.心脏结节病的形态学重新评估——基于14例日本尸检心脏的病例分析
Circ Rep. 2025 Jun 20;7(8):654-660. doi: 10.1253/circrep.CR-25-0069. eCollection 2025 Aug 8.
2
An mTORC1-Dependent Mouse Model for Cardiac Sarcoidosis.mTORC1 依赖性心肌肉状瘤病小鼠模型。
J Am Heart Assoc. 2023 Oct 3;12(19):e030478. doi: 10.1161/JAHA.123.030478. Epub 2023 Sep 26.
3
A Patient with Cardiac Sarcoidosis in Whom an Abnormal Myocardial Uptake of Fluorine-18 Fluorodeoxyglucose and Sustained Ventricular Tachycardia Recurred 3.5 Years after Discontinuing Oral Corticosteroid Therapy.

本文引用的文献

1
Myocardial Scar and Fibrosis: The Ultimate Mediator of Outcomes?心肌瘢痕和纤维化：结局的终极介导者？
Heart Fail Clin. 2019 Apr;15(2):179-189. doi: 10.1016/j.hfc.2018.12.009. Epub 2019 Feb 2.
2
Spontaneous Reduction in Abnormal Myocardial Uptake of Fluorine-18 Fluorodeoxygluose in a Patient with Cardiac Sarcoidosis.心脏结节病患者异常心肌摄取氟-18氟脱氧葡萄糖的自发消退
Int Heart J. 2018 May 30;59(3):647-651. doi: 10.1536/ihj.17-315. Epub 2018 May 20.
3
Clinical impact of the presence of macrophages in endomyocardial biopsies of patients with dilated cardiomyopathy.
一位患有心脏结节病的患者，停止口服皮质类固醇治疗 3.5 年后，氟-18 氟脱氧葡萄糖的心肌摄取异常，并再次出现持续性室性心动过速。
Intern Med. 2020 Sep 15;59(18):2275-2280. doi: 10.2169/internalmedicine.4524-20. Epub 2020 Jun 15.
扩张型心肌病患者心肌活检中巨噬细胞存在的临床影响。
Eur J Heart Fail. 2017 Apr;19(4):490-498. doi: 10.1002/ejhf.767. Epub 2017 Feb 20.
4
Effect of Corticosteroid Therapy on Long-Term Clinical Outcome and Left Ventricular Function in Patients With Cardiac Sarcoidosis.皮质类固醇疗法对心脏结节病患者长期临床结局及左心室功能的影响
Circ J. 2015;79(7):1593-600. doi: 10.1253/circj.CJ-14-1275. Epub 2015 Apr 16.
5
Cardiac sarcoidosis: epidemiology, characteristics, and outcome over 25 years in a nationwide study.心脏结节病：一项全国性研究中 25 年来的流行病学、特征和结局。
Circulation. 2015 Feb 17;131(7):624-32. doi: 10.1161/CIRCULATIONAHA.114.011522. Epub 2014 Dec 19.
6
Deterioration of cardiac function during the progression of cardiac sarcoidosis: diagnosis and treatment.
Intern Med. 2014;53(15):1595-605. doi: 10.2169/internalmedicine.53.2784. Epub 2014 Aug 1.
7
HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis.心脏结节病相关心律失常诊断与管理的HRS专家共识声明
Heart Rhythm. 2014 Jul;11(7):1305-23. doi: 10.1016/j.hrthm.2014.03.043. Epub 2014 May 9.
8
Severe myocardial fibrosis in a patient with cardiac sarcoidosis.心脏结节病患者的严重心肌纤维化。
Acta Cardiol. 2013 Apr;68(2):231-2. doi: 10.1080/ac.68.2.2967288.
9
The pathogenesis of cardiac fibrosis.心脏纤维化的发病机制。
Cell Mol Life Sci. 2014 Feb;71(4):549-74. doi: 10.1007/s00018-013-1349-6. Epub 2013 May 7.
10
Protective and pathogenic functions of macrophage subsets.巨噬细胞亚群的保护和致病功能。
Nat Rev Immunol. 2011 Oct 14;11(11):723-37. doi: 10.1038/nri3073.